Neuren Pharmaceuticals LimitedASX: NEU

Approval received for final stage of NNZ-2591 clinical trial

Nov 19, 2020 at 3:32 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment